Skip to main content

Table 3 Logistic regression analysis of the risk factors for distinguishing HCC from ICC

From: Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma

Variables β OR (95% CI) p value
Development set
Sex (Male vs Female) 1.293 3.645 (1.398–9.504) 0.008
HBsAg (Positive vs Negative) 1.010 2.747 (1.054–7.159) 0.039
Cirrhosis (Yes vs No) 1.885 6.590 (2.648–16.398)  < 0.001
MPV (fL) 0.464 1.590 (1.171–2.159) 0.003
AST (U/L) 0.002 1.002 (1.000–1.003) 0.018
AFP (ng/mL) − 0.026 0.974 (0.957–0.991) 0.003
CA19-9 (U/mL) 0.067 1.069 (1.015–1.126) 0.011
Validation set
Sex (Male vs Female) 2.669 14.424 (2.795–74.439) 0.001
Haemoglobin (g/L) − 0.058 0.944 (0.910–0.979) 0.002
MPV (fL) 1.388 4.007 (1.226–13.094) 0.022
Total bilirubin (μmol/L) − 0.014 0.986 (0.973–0.999) 0.040
AFP (ng/mL) 0.007 1.007 (1.002–1.012) 0.008
CA19-9 (U/mL) − 0.015 0.985 (0.972–0.998) 0.020
  1. OR, odds ratio; CI, confidence interval. Abbreviations: see to Table 1